T clinical manifestations of the same systemic granulomatous vasculitis, predominantly affect older persons. ' Huston and colleagues estimated the prevalence to be 1 in 750 persons older than 50 years of age.' Temporal arteritis often requires high and sometimes sustained corticosteroid therapy to prevent the development of sight threatening complications.'-' Often, corticosteroids alone are used for the entire length of the treatment course, which may exceed 1 year. This is in contrast to other collagen vascular diseases/vasculitides, in which other steroid-sparing immunosuppressive agents are used in combination to reduce the dose of corticosteroids. 8 Corticosteroids exert their immunosuppressive effect principally on cell-mediated immunity.' This arm of the immune system is particularly important for defense against a variety of different intracellular pathogens. Thus, patients receiving corticosteroid therapy are at increased risk of infection caused by intracellular organisms. Although intracellular pathogens are frequently thought of in the differential diagnosis of pneumonia and sepsis syndrome in patients with hematological malignancies or transplants, these types of pathogens are rarely considered in the differential diagnosis of patients with temporal arteritis. We report the cases of three patients who received corticosteroids for temporal arteritis and who subsequently were infected with opportunistic pathogens. In all three, the opportunistic infection was not considered with the initial diagnosis.
CASE REPORTS Case 1
A 77-year-old man was diagnosed as having temporal arteritis in October 1994. He was treated with 60 mg prednisone daily and showed improvement in his symptoms of headache and muscle weakness. His prednisone dosage was reduced to 40 mg by January 1995. In February 1995, he was admitted to hospital for the treatment of pneumonia. Chest roentgenogram revealed bibasilar patchy infiltrates. Treatment with ceftriaxone and erythromycin followed by amoxicillinklavulanic acid and clarithromycin failed to clear the chest roentgenogram findings. He had several subsequent hospitalizations over the next 3 months for the treatment of Clostridium dificile colitis, funguria, and a Pseudomonas aeruginosa and enterococcal urinary tract infection.
In July 1995, the patient was admitted to hospital with dyspnea, difficulty walking, and vomiting. He was taking 25 mg prednisone daily. On examination, he had a temperature of 985°F (37.1°C), and respirations were 28/min. He was alert but distractable and had no signs of meningismus. Neurological exam revealed intact cranial nerve function and normal peripheral power and sensation with symmetrical reflexes. The hemoglobin was 12.4 g/dL, white blood cell count was 1 6,900/mm3, platelets were 25,000/mm3. Chest roentgenogram revealed persistent bilateral, patchy infiltrates, predominantly affecting the lower lobes ( Figure 1) .
Bronchoscopy was performed, and transbronchial biopsy revealed chronic inflammation and budding yeasts. Culture of bronchoalveolar fluid yielded Cryptococcus neoformans. Cerebrospinal fluid microscopy showed budding yeasts, cryptococcal antigen was positive at a titer of 1:2048, and culture was positive for C. neoformans. Urine culture was positive for C. neoformans, but serum cryptococcal antigen titer was negative. The patient was treated with 6 weeks of amphotericin B (0.4 mg/kg/d) plus flucytosine (adjusted for renal function). After completion of this therapy, fluconazole 50 mg daily (adjusted for creatinine of 2.3 mg/ dL) was begun. Although his pulmonary and mental status improved on this regimen, he died at home 4 weeks after discharge, and autopsy was not obtained.
Case 2
A 71-year-old man was diagnosed with temporal arteritis in August 1995. He was prescribed a dosage of 60 mg of Prednisone daily, with improvement of diplopia and visual loss. In October 1995, he was admitted to hospital with cellulitis of his right lower extremity and a malleolar ulcer attributable to peripheral vascular disease. Following intravenous antibiotics and debridement, he was admitted to the Geriatric Evaluation and Management service for rehabilitation.
In November 1995, while on a daily dosage of 40 mg prednisone, the patient became dyspneic, with rigors and a fever of 100.4"F (38°C). White blood cell count was 9600/ mmY3 (86% neutrophils), and hemoglobin was 15.4 g/dL. A chest roentgenogram revealed diffuse bilateral infiltrates (Figure 2) . Ampicillin/sulbactam, 1.5 g every 8 hours, was begun. His condition deteriorated and he was transferred to the intensive care unit where arterial blood gases showed pH 7.5, PaOz 61 mm Hg, PaC02 28 mm Hg on 100% O2 face mask. The following day he underwent bronchoscopy. Cytological examination of the bronchoalveolar fluid revealed many Pneumocystis carinii organisms. Despite treatment with intravenous trimethopridsulphamethoxazole therapy (15 mg/ Wd), the patient's condition did not improve. His course was complicated by a myocardial infarction, the development of acute renal failure, P . aeruginosa pneumonia, and an upper gastrointestinal bleed. He died 17 days after admission to the intensive care unit.
Case 3
A-74-year old man was admitted in August 1995 for the treatment of a urinary tract infection caused by Serratia marcescens and osteomyelitis underlying a malleolar ulcer. His medical history was significant for insulin-requiring diabetes mellitus with nephropathy, hypothyroidism, and hypertension. In October 1995, he complained of blurred vision and jaw claudication, and examination revealed left temporal artery tenderness. A presumptive diagnosis of temporal arteritis was made, based on his clinical picture and a temporal artery biopsy, which was suggestive, but not diagnostic, of temporal arteritis. His symptoms responded well to prednisone 60 mg daily, and 14 days into corticosteroid therapy, the Westergren sedimentation rate had fallen from 110 to 25 m d h . Prednisone was gradually tapered such that he was receiving 40 mg daily by November 1995. On Novmber 27, 1995, he developed stupor, dyspnea, and a temperature of 101°F (38.3"C). Despite the correction of his blood glucose of 24 mg/dL to normal, his somnolence did not improve. His hemoglobin was 13.5 g/dL, white blood cell count was 1 8,900/mm3,and platelets were 126,000/mm.3 Arterial blood gases showed a pH of 7.5, PaO, 49 mmHg, PaC02 38.5 mmHg and bicarbonate of 30 mmol/L on room air. A chest 
DISCUSSION
These three cases illustrate that patients in whom temporal arteritis is treated with corticosteroids are at increased risk of infection with opportunistic pathogens such as P. carinii, L. monocytogenes, and C. neoformans. Increasingly, there is recognition that these organisms are widely distributed in the environment and can be acquired easily. However, disease occurs almost entirely in patients who are immunocompromised.
Various reports have suggested that mortality in patients with temporal arteritis is increased compared with the norma1 age-matched p~p u l a t i o n .~-~~~' Other authors have not shown such an increase in mortality."-7 However, if mortality is increased, it is unclear if such an increase is related to the disease itself or complications of its treatment. Longitudinal cohort studies which contain small numbers of patients do not show statistically significant increases in infection rates for patients who have temporal arteritis and who are treated with corticosteroids, when compared with the normal populati~n.,'"'~ Anecdotal reports of opportunistic infections reported in temporal arteritis have included invasive aspergill o s i~, '~,~~ nocardiasis," t u b e r~u l o s i s ,~"~ varicella-zoster i n f e~t i o n '~ and pneumocystis pneumonia.20,21 P. carinii pneumonia (PCP) has become increasingly important with the epidemic of acquired immune deficiency syndrome (AIDS).22 However, this organism is a recognized complication of many other immunodeficiency states, including immunoglobulin deficiencies, malnutrition, hematological malignancies, and transplantati~n.~~-~' Moreover, with the advent of significant immunosuppressive regimens for many rheumatological and dermatological disorders, the in- 
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cidence of PCP in patients with these diseases has increased in recent years. 29 Crayton and Sundstrom reported a case of PCP occurring in a 71-year-old man who had temporal arteritis and who had received corticosteroids for 5 weeks.20 In a retrospective review of all non-AIDS-associated episodes of PCP diagnosed at the Mayo Clinic between 1985 and 1991, Yale and Limper described five cases of PCP in patients with temporal arteritk21 Other retrospective reviews of PCP do not re ort PCP occurring in patients with temporal arteriti~~~-"although patients with other collagen vascular disorders, such as Wegener's granulomatosus, systemic lupus erythematosus, dermatomyositis, and rheumatoid arthritis have been reported with PCP. 27, 28 Prophylaxis against PCP has become standard treatment for patients with AIDS and acute leukemia and following transplantation. However, prophylaxis is not recommended routinely for patients undergoing treatment of connective tissuekollagen vascular disorders, inflammatory bowel disease, or dermatological conditions. Sepkowitz et al. have suggested that reasons for changes in the spectrum of underlying disorders seen in patients with PCP over time, in part, reflect this changing use of pro phyla xi^.^' There is still no concensus regarding the use of prophylaxis against PCP with trimethoprindsulphamethoxazole in patients with temporal arteritis treated with corticosteroids. Because the numbers of infections in patients with temporal arteritis caused by P. carinii is small, the risk of side effects from the trimethoprid sulphamethoxazole may outweigh the benefits obtained by routine use of the drug.
L. monocytogenes has been reported rarely as a complication of temporal arteritis. Pigrau et al. noted in a brief communication that five of 51 adults with listeriosis had "systemic lupus erythematosus or Horton's (temporal) arteritis," but no specific patient data were reported.31 This lack of cases is perhaps surprising given the incidence of listeriosis throughout the world. Skogberg, et al. described 74 patients with Listeria infection in Finland; five of these patients had collagen vascular disorders." Kraus et al. described eight patients who had collagen vascular diseases other than temporal arteritis and who developed listerio~is.~~ Of 57 adults with listeriosis in an outbreak associated with soft cheese ingestion in Switzerland, none had v a s~u l i t i s .~~ Although not specifically reported, it seems likely that any patient with listeriosis complicating temporal arteritis could have been grouped with "collagen vascular disorders" in previous series.
There is clearly an increased risk of listeriosis with increasing age.12 The Centers for Disease Control and Prevention have estimated that sporadic cases of Listeria infection occur in the United States at a rate of 7.1 per lo6 population per year.12 Excluding pregnancy-associated cases, the incidence is lowest and relatively constant during the first 4 decades of life and increases thereafter. By age 70, the incidence is 21 cases per lo6 population. Although this increase in incidence may be explained by a waning immune system in older people, it is just as likely that decreasing gastric acidity allows a larger inoculum of this food-borne athogen to pass through the stomach and cause d i~e a s e .~~,~.
C. neoformans is an encapsulated yeast that most commonly causes chronic meningitis. 14, 36 It appears that intact cell-mediated immune systems are important host defenses against this organism. The incidence of cryptococcosis has P increased with the AIDS epidemi~'~; in non-HIV-infected people, common underlying diseases include lymphoma, leukemia, and tran~plantation.'~~~~~~~ Ho wever, in the non-HIV population, up to 50% may have no known associated immunosuppressive disease. l3 Schimpff and Bennett showed subtle in vitro abnormalities of cell-mediated immunity in six apparently normal individuals with cryptococcal disease and suggested that these defects might explain the susceptibility to this fungus.38
The older adult may present with atypical manifestations of meningitis; there are anecdotal reports of cryptococcal meningitis presenting as dementia or new onset confusion in the older a d~l t .~~.~' We believe that there are no reports of cryptococcal disease complicating temporal arteritis although corticosteroid therapy in sarcoidosis and systemic lupus erythematosus has been associated with cryptococcosis. 14, 3637 Most probably, our patients were at risk for opportunistic infections for at least three possible reasons. It is likely that the most important of these risk factors was the use of corticosteroids. Corticosteroids have been shown to increase the risk of infection in both animals and human^.^^,^^ Recently, Stuck et al. examined the association between corticosteroid therapy and subsequent infection using a metaanalysis of 71 controlled clinical trials in which patients were randomized to treatment with or without cortico~teroids.~~ The relative risk of infection was 1.6 (confidence interval 0.9-2.3) in patients receiving corticosteroids but was greater in those with underlying neurological disease. This effect was cumulative and dose-dependent. No increased rate was seen in those receiving < l o mg daily or <700 mg total. At the cellular level, corticosteroid therapy inhibits T-lymphocyte function and IL-2 production and suppresses monocyte function and production. ' The use of corticosteroids has been shown to contribute to the risk of infection with P. carinii and C. neoformans in both animals and humans.10~13i44 Su ccessful infection of rats with P. carinii requires the animals to be treated with corticosteroids in order to produce pneumonia." Experimental animal studies have shown a decrease in the size of the inoculum required to induce L. monocytogenes infection in steroid-treated rats when compared with rats not treated with cortic~steroids.~~ Secondly, our patients were all more than 65 years of age. Aging has been shown to decrease cell-mediated immunity in both animal models and human^.^^-^' Older people have been shown to be at increased risk for many a ents Age alone is thought to be a sufficient predisposing factor for acquisition of these diseases. No such clearly defined age risk exists for PCP, but interestingly, Jacobs et al. described a cluster of five immunocompetent patients, who were all more than 65 years old and who were diagnosed with PCP.'l Thirdly, the presence of temporal arteritis may have contributed to a dysregulation of the immune system with concomitant increased susceptibility to infection. Certainly, macrophage and T cell activation, thought to be related to the disease itself has been found in patients with temporal arterit k S 2 However, temporal arteritis is a disease which rarely affects those less than 50 years old and in whom high dose corticosteroid therapy is the standard treatment regimen. Thus, ability to dissect the relative contribution to infection from temporal arteritis, therapy, and age is difficult.
including listeriosis, cryptococcosis, and tuberculosis. ,g49,5;
Patients with temporal arteritis often have dramatic symptomatic improvement with corticosteroid therapy. High doses are required to initially control symptoms, and relapses may occur if corticosteroids are tapered too quickly. Patients with temporal arteritis are commonly more than 50 years old and are exposed to long courses of corticosteroids with all their attendant complications in older people, including diabetes mellitus, altered mentation, and osteoporosis. The patient with temporal arteritis is, therefore, at risk from infections that which may be uncommon otherwise, and we should remain cognizant of this possibility. Diagnoses of possible opportunistic infections should be actively pursued to ensure such patients are given appropriate therapy.
